Evidence map›Paper›PMID 42745010›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Acute effects of AT

Divya Prasad, Ina Pelster, Leonardo Outes, Amy Gillespie, Diego A Pizzagalli, Mike Rinck, Andrea Reinecke

Abstract read
PubMed Publisher
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Divya PrasadDepartment of Psychiatry, University of Oxford, Oxford, UK. divya.prasad@psych.ox.ac.uk.ORCID http://orcid.org/0000-0002-5747-1036
Ina PelsterDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0009-0003-4028-380X
Leonardo OutesDepartment of Psychiatry, University of Oxford, Oxford, UK.
Amy GillespieDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4640-699X
Diego A PizzagalliDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7772-1143
Mike RinckBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Andrea ReineckeDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5130-7318

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH068376/MH119467
6 · The paper itself

Abstract

Recent evidence implicates the renin angiotensin system (RAS) in various cognitive markers of depression, including dysfunctional reward processing. Yet, it remains unknown whether these effects extend to other markers implicated in depression and its treatment, such as approach-avoidance motivations that reflect innate drives to approach reward and evade harm. We sought to examine the impact of acute losartan, an angiotensin type 1 (AT

Identifiers

PMID42745010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.